Village doctor telehealth care for rural older adults with atrial fibrillation and heart failure
Tests village doctor-led, telehealth-supported care in rural adults with atrial fibrillation and heart failure.
Plain-language title generated from the registry record
Registry title: A Village Doctor-led Telehealth Supported Improvement of Outcomes of AF Patients With Heart Failure Due to Reduced or Preserved Ejection Fraction: The MIRACLE-AF 2 Heart Failure Management Trial (MIRACLE AF-HF)
Key facts
- Where
- Xuzhou, Yancheng, and Yangzhou, ChinaSee the 3 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 65 and 80 years old?
Source: NCT07492524, who can take part
Where in China
- Village Clinics in Suining County, Jiangsu ProvinceXuzhou, ChinaTaking people
- Village Clinics in Dongtai City, Jiangsu ProvinceYancheng, ChinaTaking people
- Village Clinics in Jiangdu District, Jiangsu ProvinceYangzhou, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Jiangsu Taizhou People's Hospital
- Trial code
- NCT07492524
- Record updated
- 7 October 2026
- Original description
The primary objective is to determine whether a telemedicine-supported, village doctor-led integrated management model, AF-HF comorbidity ABC pathway and enhanced patient education, improves clinical outcomes compared with usual care among rural residents aged 65-80 years with AF and HF. The trial will evaluate whether integrated management reduces the MAGGIC HF risk score at 12 months (phase 1) and whether it reduces a composite cardiovascular endpoint, including cardiovascular death, ischemic or hemorrhagic stroke, hospitalization for worsening heart failure or acute coronary syndrome, and emergency visits due to atrial fibrillation over 36 months (phase 2). An extended observational follow-up, the composite cardiovascular endpoint observational follow-up study, will be conducted at Year 6 to evaluate long-term effects.Read full original descriptionShow less
A Village Doctor-led Telehealth Supported Improvement of Outcomes of AF Patients With Heart Failure Due to Reduced or Preserved Ejection Fraction: The MIRACLE-AF 2 Heart Failure Management Trial (MIRACLE AF-HF)
The primary objective is to determine whether a telemedicine-supported, village doctor-led integrated management model, AF-HF comorbidity ABC pathway and enhanced patient education, improves clinical outcomes compared with usual care among rural residents aged 65-80 years with AF and HF. The trial will evaluate whether integrated management reduces the MAGGIC HF risk score at 12 months (phase 1) and whether it reduces a composite cardiovascular endpoint, including cardiovascular death, ischemic or hemorrhagic stroke, hospitalization for worsening heart failure or acute coronary syndrome, and emergency visits due to atrial fibrillation over 36 months (phase 2). An extended observational follow-up, the composite cardiovascular endpoint observational follow-up study, will be conducted at Year 6 to evaluate long-term effects.
Exclusion: Severe renal insufficiency (Ccr < 30ml/min) or ongoing dialysis treatment; Cardiac insufficiency secondary to correctable causes, including hyperthyroid heart disease, anemic heart disease, or uncorrected congenital heart disease; Chronic obstructive pulmonary disease (COPD) complicated by type II respiratory failure; Special populations, including patients with mental illnesses; Expected life expectancy of less than 12 months; Indications for pacemaker implantation without having undergone implantation.